IBCSG 69-23 GeparPiPPa

  • A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K inhibitor inavolisib in patients with HER2-positive, HR-positive, PIK3CA mutant early breast cancer- GeparPiPPa.

     
        object(stdClass)#2075 (33) {
  ["id"]=>
  int(58)
  ["title"]=>
  string(7) "Persons"
  ["name"]=>
  string(7) "persons"
  ["checked_out"]=>
  NULL
  ["checked_out_time"]=>
  NULL
  ["note"]=>
  string(0) ""
  ["state"]=>
  int(1)
  ["access"]=>
  int(1)
  ["created_time"]=>
  string(19) "2026-05-11 08:21:36"
  ["created_user_id"]=>
  int(404)
  ["ordering"]=>
  int(1)
  ["language"]=>
  string(1) "*"
  ["fieldparams"]=>
  object(Joomla\Registry\Registry)#2100 (3) {
    ["data":protected]=>
    object(stdClass)#2097 (3) {
      ["repeat"]=>
      string(1) "1"
      ["max_rows"]=>
      string(0) ""
      ["options"]=>
      object(stdClass)#2095 (4) {
        ["option0"]=>
        object(stdClass)#2096 (2) {
          ["customfield"]=>
          string(2) "54"
          ["render_values"]=>
          string(1) "1"
        }
        ["option1"]=>
        object(stdClass)#2032 (2) {
          ["customfield"]=>
          string(2) "55"
          ["render_values"]=>
          string(1) "1"
        }
        ["option2"]=>
        object(stdClass)#2033 (2) {
          ["customfield"]=>
          string(2) "60"
          ["render_values"]=>
          string(1) "1"
        }
        ["option3"]=>
        object(stdClass)#2031 (2) {
          ["customfield"]=>
          string(2) "57"
          ["render_values"]=>
          string(1) "1"
        }
      }
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["params"]=>
  object(Joomla\Registry\Registry)#2099 (3) {
    ["data":protected]=>
    object(stdClass)#2036 (16) {
      ["hint"]=>
      string(0) ""
      ["class"]=>
      string(0) ""
      ["label_class"]=>
      string(0) ""
      ["show_on"]=>
      string(0) ""
      ["showon"]=>
      string(0) ""
      ["render_class"]=>
      string(0) ""
      ["value_render_class"]=>
      string(0) ""
      ["showlabel"]=>
      string(1) "1"
      ["label_render_class"]=>
      string(0) ""
      ["display"]=>
      string(1) "0"
      ["prefix"]=>
      string(0) ""
      ["suffix"]=>
      string(0) ""
      ["layout"]=>
      string(0) ""
      ["display_readonly"]=>
      string(1) "2"
      ["searchindex"]=>
      string(1) "0"
      ["form_layout"]=>
      string(0) ""
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["type"]=>
  string(7) "subform"
  ["default_value"]=>
  string(0) ""
  ["context"]=>
  string(19) "com_content.article"
  ["group_id"]=>
  int(3)
  ["label"]=>
  string(7) "Persons"
  ["description"]=>
  string(0) ""
  ["required"]=>
  int(0)
  ["only_use_in_subform"]=>
  int(0)
  ["language_title"]=>
  NULL
  ["language_image"]=>
  NULL
  ["editor"]=>
  NULL
  ["access_level"]=>
  string(6) "Public"
  ["author_name"]=>
  string(9) "ibcsgchef"
  ["group_title"]=>
  string(11) "Person List"
  ["group_access"]=>
  int(1)
  ["group_state"]=>
  int(1)
  ["group_note"]=>
  string(0) ""
  ["value"]=>
  string(0) ""
  ["rawvalue"]=>
  string(0) ""
}

        object(stdClass)#2264 (33) {
  ["id"]=>
  int(59)
  ["title"]=>
  string(16) "Persons Advisory"
  ["name"]=>
  string(16) "persons-advisory"
  ["checked_out"]=>
  NULL
  ["checked_out_time"]=>
  NULL
  ["note"]=>
  string(0) ""
  ["state"]=>
  int(1)
  ["access"]=>
  int(1)
  ["created_time"]=>
  string(19) "2026-05-11 08:23:30"
  ["created_user_id"]=>
  int(404)
  ["ordering"]=>
  int(2)
  ["language"]=>
  string(1) "*"
  ["fieldparams"]=>
  object(Joomla\Registry\Registry)#2098 (3) {
    ["data":protected]=>
    object(stdClass)#2073 (3) {
      ["repeat"]=>
      string(1) "1"
      ["max_rows"]=>
      string(0) ""
      ["options"]=>
      object(stdClass)#2072 (4) {
        ["option0"]=>
        object(stdClass)#2074 (2) {
          ["customfield"]=>
          string(2) "54"
          ["render_values"]=>
          string(1) "1"
        }
        ["option1"]=>
        object(stdClass)#2071 (2) {
          ["customfield"]=>
          string(2) "55"
          ["render_values"]=>
          string(1) "1"
        }
        ["option2"]=>
        object(stdClass)#2062 (2) {
          ["customfield"]=>
          string(2) "60"
          ["render_values"]=>
          string(1) "1"
        }
        ["option3"]=>
        object(stdClass)#2063 (2) {
          ["customfield"]=>
          string(2) "57"
          ["render_values"]=>
          string(1) "1"
        }
      }
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["params"]=>
  object(Joomla\Registry\Registry)#2035 (3) {
    ["data":protected]=>
    object(stdClass)#2067 (16) {
      ["hint"]=>
      string(0) ""
      ["class"]=>
      string(0) ""
      ["label_class"]=>
      string(0) ""
      ["show_on"]=>
      string(0) ""
      ["showon"]=>
      string(0) ""
      ["render_class"]=>
      string(0) ""
      ["value_render_class"]=>
      string(0) ""
      ["showlabel"]=>
      string(1) "1"
      ["label_render_class"]=>
      string(0) ""
      ["display"]=>
      string(1) "0"
      ["prefix"]=>
      string(0) ""
      ["suffix"]=>
      string(0) ""
      ["layout"]=>
      string(0) ""
      ["display_readonly"]=>
      string(1) "2"
      ["searchindex"]=>
      string(1) "0"
      ["form_layout"]=>
      string(0) ""
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["type"]=>
  string(7) "subform"
  ["default_value"]=>
  string(0) ""
  ["context"]=>
  string(19) "com_content.article"
  ["group_id"]=>
  int(3)
  ["label"]=>
  string(16) "Persons Advisory"
  ["description"]=>
  string(0) ""
  ["required"]=>
  int(0)
  ["only_use_in_subform"]=>
  int(0)
  ["language_title"]=>
  NULL
  ["language_image"]=>
  NULL
  ["editor"]=>
  NULL
  ["access_level"]=>
  string(6) "Public"
  ["author_name"]=>
  string(9) "ibcsgchef"
  ["group_title"]=>
  string(11) "Person List"
  ["group_access"]=>
  int(1)
  ["group_state"]=>
  int(1)
  ["group_note"]=>
  string(0) ""
  ["value"]=>
  string(0) ""
  ["rawvalue"]=>
  string(0) ""
}

        object(stdClass)#2265 (33) {
  ["id"]=>
  int(48)
  ["title"]=>
  string(9) "intro all"
  ["name"]=>
  string(9) "intro-all"
  ["checked_out"]=>
  NULL
  ["checked_out_time"]=>
  NULL
  ["note"]=>
  string(0) ""
  ["state"]=>
  int(1)
  ["access"]=>
  int(1)
  ["created_time"]=>
  string(19) "2019-07-17 14:20:56"
  ["created_user_id"]=>
  int(405)
  ["ordering"]=>
  int(8)
  ["language"]=>
  string(1) "*"
  ["fieldparams"]=>
  object(Joomla\Registry\Registry)#2037 (3) {
    ["data":protected]=>
    object(stdClass)#2069 (4) {
      ["buttons"]=>
      string(0) ""
      ["width"]=>
      string(0) ""
      ["height"]=>
      string(0) ""
      ["filter"]=>
      string(8) "safehtml"
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["params"]=>
  object(Joomla\Registry\Registry)#2064 (3) {
    ["data":protected]=>
    object(stdClass)#2066 (10) {
      ["hint"]=>
      string(0) ""
      ["class"]=>
      string(0) ""
      ["label_class"]=>
      string(0) ""
      ["show_on"]=>
      string(0) ""
      ["render_class"]=>
      string(5) "intro"
      ["showlabel"]=>
      string(1) "0"
      ["label_render_class"]=>
      string(0) ""
      ["display"]=>
      string(1) "2"
      ["layout"]=>
      string(0) ""
      ["display_readonly"]=>
      string(1) "2"
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["type"]=>
  string(6) "editor"
  ["default_value"]=>
  string(0) ""
  ["context"]=>
  string(19) "com_content.article"
  ["group_id"]=>
  int(2)
  ["label"]=>
  string(9) "intro all"
  ["description"]=>
  string(0) ""
  ["required"]=>
  int(0)
  ["only_use_in_subform"]=>
  int(0)
  ["language_title"]=>
  NULL
  ["language_image"]=>
  NULL
  ["editor"]=>
  NULL
  ["access_level"]=>
  string(6) "Public"
  ["author_name"]=>
  string(4) "artd"
  ["group_title"]=>
  string(5) "trial"
  ["group_access"]=>
  int(1)
  ["group_state"]=>
  int(1)
  ["group_note"]=>
  string(0) ""
  ["value"]=>
  string(283) "
A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K inhibitor inavolisib in patients with HER2-positive, HR-positive, PIK3CA mutant early breast cancer- GeparPiPPa.
"
  ["rawvalue"]=>
  string(283) "
A randomized, open-label, phase II trial comparing neoadjuvant endocrine therapy in combination with trastuzumab, pertuzumab +/- the PI3K inhibitor inavolisib in patients with HER2-positive, HR-positive, PIK3CA mutant early breast cancer- GeparPiPPa.
"
}

        object(stdClass)#2266 (34) {
  ["id"]=>
  int(49)
  ["title"]=>
  string(17) "Repeatable Fields"
  ["name"]=>
  string(17) "repeatable-fields"
  ["checked_out"]=>
  NULL
  ["checked_out_time"]=>
  NULL
  ["note"]=>
  string(0) ""
  ["state"]=>
  int(1)
  ["access"]=>
  int(1)
  ["created_time"]=>
  string(19) "2019-07-17 14:21:53"
  ["created_user_id"]=>
  int(405)
  ["ordering"]=>
  int(9)
  ["language"]=>
  string(1) "*"
  ["fieldparams"]=>
  object(Joomla\Registry\Registry)#2068 (3) {
    ["data":protected]=>
    object(stdClass)#2061 (2) {
      ["repeat"]=>
      string(1) "1"
      ["options"]=>
      object(stdClass)#2105 (3) {
        ["option0"]=>
        object(stdClass)#2065 (2) {
          ["customfield"]=>
          int(51)
          ["render_values"]=>
          string(1) "1"
        }
        ["option1"]=>
        object(stdClass)#2106 (2) {
          ["customfield"]=>
          int(52)
          ["render_values"]=>
          string(1) "1"
        }
        ["option2"]=>
        object(stdClass)#2107 (2) {
          ["customfield"]=>
          int(53)
          ["render_values"]=>
          string(1) "1"
        }
      }
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["params"]=>
  object(Joomla\Registry\Registry)#2060 (3) {
    ["data":protected]=>
    object(stdClass)#2109 (10) {
      ["hint"]=>
      string(0) ""
      ["class"]=>
      string(0) ""
      ["label_class"]=>
      string(0) ""
      ["show_on"]=>
      string(0) ""
      ["render_class"]=>
      string(0) ""
      ["showlabel"]=>
      string(1) "1"
      ["label_render_class"]=>
      string(0) ""
      ["display"]=>
      string(1) "0"
      ["layout"]=>
      string(0) ""
      ["display_readonly"]=>
      string(1) "2"
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["type"]=>
  string(7) "subform"
  ["default_value"]=>
  string(0) ""
  ["context"]=>
  string(19) "com_content.article"
  ["group_id"]=>
  int(2)
  ["label"]=>
  string(15) "Repeatable Area"
  ["description"]=>
  string(0) ""
  ["required"]=>
  int(0)
  ["only_use_in_subform"]=>
  int(0)
  ["language_title"]=>
  NULL
  ["language_image"]=>
  NULL
  ["editor"]=>
  NULL
  ["access_level"]=>
  string(6) "Public"
  ["author_name"]=>
  string(4) "artd"
  ["group_title"]=>
  string(5) "trial"
  ["group_access"]=>
  int(1)
  ["group_state"]=>
  int(1)
  ["group_note"]=>
  string(0) ""
  ["value"]=>
  string(9) "
    "
  ["rawvalue"]=>
  string(10297) "{"row0":{"field51":"Protocol Documents","field52":"
    Protocol<\/h2>\r\n
              object(stdClass)#2267 (33) {
  ["id"]=>
  int(50)
  ["title"]=>
  string(5) "aside"
  ["name"]=>
  string(5) "aside"
  ["checked_out"]=>
  NULL
  ["checked_out_time"]=>
  NULL
  ["note"]=>
  string(0) ""
  ["state"]=>
  int(1)
  ["access"]=>
  int(1)
  ["created_time"]=>
  string(19) "2019-07-17 14:22:30"
  ["created_user_id"]=>
  int(405)
  ["ordering"]=>
  int(10)
  ["language"]=>
  string(1) "*"
  ["fieldparams"]=>
  object(Joomla\Registry\Registry)#2070 (3) {
    ["data":protected]=>
    object(stdClass)#2111 (4) {
      ["buttons"]=>
      string(0) ""
      ["width"]=>
      string(0) ""
      ["height"]=>
      string(0) ""
      ["filter"]=>
      string(8) "safehtml"
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["params"]=>
  object(Joomla\Registry\Registry)#2108 (3) {
    ["data":protected]=>
    object(stdClass)#2113 (10) {
      ["hint"]=>
      string(0) ""
      ["class"]=>
      string(0) ""
      ["label_class"]=>
      string(0) ""
      ["show_on"]=>
      string(0) ""
      ["render_class"]=>
      string(15) "sidebar-content"
      ["showlabel"]=>
      string(1) "0"
      ["label_render_class"]=>
      string(0) ""
      ["display"]=>
      string(1) "3"
      ["layout"]=>
      string(0) ""
      ["display_readonly"]=>
      string(1) "2"
    }
    ["initialized":protected]=>
    bool(true)
    ["separator":protected]=>
    string(1) "."
  }
  ["type"]=>
  string(6) "editor"
  ["default_value"]=>
  string(0) ""
  ["context"]=>
  string(19) "com_content.article"
  ["group_id"]=>
  int(2)
  ["label"]=>
  string(5) "aside"
  ["description"]=>
  string(0) ""
  ["required"]=>
  int(0)
  ["only_use_in_subform"]=>
  int(0)
  ["language_title"]=>
  NULL
  ["language_image"]=>
  NULL
  ["editor"]=>
  NULL
  ["access_level"]=>
  string(6) "Public"
  ["author_name"]=>
  string(4) "artd"
  ["group_title"]=>
  string(5) "trial"
  ["group_access"]=>
  int(1)
  ["group_state"]=>
  int(1)
  ["group_note"]=>
  string(0) ""
  ["value"]=>
  string(1307) "
      Study Chair
      Prof. Dr. Sibylle Loibl
      

      Statistician
      Dr. Natalie Filmann, GBG Forschungs GmbH 
      

      Trial Coordinator
      Dorene Polizzi
      

      

      Monitoring
      ETOP IBCSG Partners Foundation
      Coordinating Center, Bern, Switzerland
      Phone: +41 31 511 94 00
      Fax: +41 31 511 94 01
      Email: This email address is being protected from spambots. You need JavaScript enabled to view it.
      

      Targeted Accrual
      170
      

      Protocol Release Date 
      November 15, 2023
      

      Trial Activation Date 
      December 21, 2022
      

      First Patient In 
      Q1 2023
      "
  ["rawvalue"]=>
  string(1112) "
      Study Chair
      Prof. Dr. Sibylle Loibl
      

      Statistician
      Dr. Natalie Filmann, GBG Forschungs GmbH 
      

      Trial Coordinator
      Dorene Polizzi
      

      

      Monitoring
      ETOP IBCSG Partners Foundation
      Coordinating Center, Bern, Switzerland
      Phone: +41 31 511 94 00
      Fax: +41 31 511 94 01
      Email: geparpippa-monitoring@etop.ibcsg.org
      

      Targeted Accrual
      170
      

      Protocol Release Date 
      November 15, 2023
      

      Trial Activation Date 
      December 21, 2022
      

      First Patient In 
      Q1 2023
      "
}

      • Study Chair
        Prof. Dr. Sibylle Loibl

        Statistician
        Dr. Natalie Filmann, GBG Forschungs GmbH

        Trial Coordinator
        Dorene Polizzi

        Monitoring
        ETOP IBCSG Partners Foundation
        Coordinating Center, Bern, Switzerland
        Phone: +41 31 511 94 00
        Fax: +41 31 511 94 01
        Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

        Targeted Accrual
        170

        Protocol Release Date 
        November 15, 2023

        Trial Activation Date 
        December 21, 2022

        First Patient In 
        Q1 2023

      ETOP IBCSG Partners Foundation
      Effingerstrasse 33
      3008 Bern, Switzerland

      Contact
      Phone: +41 31 511 94 00
      E-mail: contact@etop.ibcsg.org

      Member Login